| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10598999 | Bioorganic & Medicinal Chemistry Letters | 2005 | 4 Pages |
Abstract
The synthesis, biological activity and the metabolism in vitro of a novel series of EP3 antagonists have been evaluated. The very potent and selective EP2 agonist 9 is also reported.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Michel Belley, Michel Gallant, Bruno Roy, Karine Houde, Nicolas Lachance, Marc Labelle, Laird A. Trimble, Nathalie Chauret, Chun Li, Nicole Sawyer, Nathalie Tremblay, Sonia Lamontagne, Marie-Claude Carrière, Danielle Denis, Gillian M. Greig,